CDA and neoplasm: Celecoxib co-treatment completely blocked CDA-induced IDO activity in tumor lesions and TDLNs (figure 7A, B), as IDO activity levels were comparable in untreated mice with tumors and in mice co-treated with celecoxib and CDA.